Olema Pharmaceuticals (OLMA) Other Working Capital Changes (2022 - 2026)
Olema Pharmaceuticals' (OLMA) quarterly Other Working Capital Changes came in at -$313000.0 in Q1 2026, down 1.29% year-on-year from -$317104.9 in Q1 2025, and little changed on a QoQ basis from -$313000.0 in Q4 2025.
Olema Pharmaceuticals (OLMA) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 5 years of Other Working Capital Changes data on file, last reported at -$313000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 1.29% year-over-year to -$313000.0 in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 3.06% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 7.06% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$313000.0, roughly flat from -$313000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for OLMA reached as high as $4.5 million in Q4 2025 and fell as low as -$2.6 million in Q1 2026.
- Historically, Other Working Capital Changes has averaged $265588.2 across 5 years, with a median of -$30000.0 in 2024.
- Across the five-year window, Other Working Capital Changes climbed 20.25% in 2024 and declined 18.85% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$322000.0 in 2022, then climbed by 18.32% to -$263000.0 in 2023, then dropped by 15.97% to -$305000.0 in 2024, then fell by 2.62% to -$313000.0 in 2025, then changed by 0.0% to -$313000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$313000.0 in Q1 2026, -$313000.0 in Q4 2025, and -$311000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Olema Pharmaceuticals | 1.21 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -313,000.00 |
| Mar 31, 2026 | -313,000.00 |
| Mar 31, 2026 | -313,000.00 |
| Dec 31, 2025 | -313,000.00 |
| Dec 31, 2025 | -313,000.00 |
| Dec 31, 2025 | -313,000.00 |
| Sep 30, 2025 | -311,000.00 |
| Sep 30, 2025 | -311,000.00 |
| Sep 30, 2025 | -311,000.00 |
| Jun 30, 2025 | -311,000.00 |
| Jun 30, 2025 | -311,000.00 |
| Jun 30, 2025 | -311,000.00 |
| Mar 31, 2025 | -309,000.00 |
| Mar 31, 2025 | -309,000.00 |
| Mar 31, 2025 | -309,000.00 |
| Dec 31, 2024 | -305,000.00 |
| Dec 31, 2024 | -305,000.00 |
| Dec 31, 2024 | -305,000.00 |
| Sep 30, 2024 | -304,000.00 |
| Sep 30, 2024 | -304,000.00 |